Science Explorer Interactive view Map

Medical Imaging and Pathology Studies

Medical Imaging and Pathology Studies is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 44k research works in it since 1950. 7.2% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on pulmonary calcification, nodular tumors, and ossification in the lung, including conditions such as Pulmonary Alveolar Microlithiasis and Pulmonary Sclerosing Hemangioma. It also covers diagnostic approaches, genetic mutations, and clinical features associated with these pulmonary conditions.

  • Pulmonary Alveolar Microlithiasis
  • Pulmonary Sclerosing Hemangioma
  • Ciliated Muconodular Papillary Tumor
  • Diffuse Pulmonary Ossification
  • Metastatic Pulmonary Calcification
  • High-Resolution CT
  • Immunohistochemical Studies
  • SLC34A2 Gene Mutations
  • Lung Nodules
  • Clinicopathologic Analysis
Research works
44k
fractional, since 1950
In the world top 10%
3.2k
per year above
Top-10% rate
7.2%
share of its works in the world top 10%
Growth, 2013–17 → 2018–22
+10%
the tick is no change

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Medical Imaging and Pathology Studies research?

By volume, the United States and China publish the most (1.5k and 655 works in 2022–2025).

By volume, 2022–2025

  1. 1 United States 1.5k works
  2. 2 China 655 works
  3. 3 Japan 416 works
  4. 4 India 380 works
  5. 5 Germany 254 works
  6. 6 Italy 201 works
  7. 7 United Kingdom 196 works
  8. 8 France 164 works
  9. 9 Türkiye 148 works
  10. 10 Spain 146 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 36.6%China: 16.2%Japan: 10.3%India: 9.4%6 others listed: 27.5%37%largest
United States1,474 · 36.6%China655 · 16.2%Japan416 · 10.3%India380 · 9.4%6 others listed1,108 · 27.5%

Shares of the rows listed above, not of the whole node.

Which institutions lead Medical Imaging and Pathology Studies research?

By volume in 2022–2025, Cleveland Clinic publishes the most Medical Imaging and Pathology Studies research, followed by All India Institute of Medical Sciences and The University of Texas MD Anderson Cancer Center.

Where is Medical Imaging and Pathology Studies research done?

The largest centres of Medical Imaging and Pathology Studies research in 2022–2025 are Beijing (China), Tokyo (Japan), New York (United States) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Scottsdale.

Largest cities, 2022–2025

  1. 1 Beijing China 99 works
  2. 2 Tokyo Japan 86 works
  3. 3 New York United States 75 works
  4. 4 London United Kingdom 65 works
  5. 5 Paris France 56 works
  6. 6 Philadelphia United States 56 works
  7. 7 Shanghai China 55 works
  8. 8 Seoul South Korea 51 works
  9. 9 Boston United States 50 works
  10. 10 Houston United States 48 works

Where it is the local speciality

  1. ScottsdaleUS · 20.6 works7.9×
← less than its size predictsmore →

Location quotient: how much more of its research is in Medical Imaging and Pathology Studies than the world average.

See Medical Imaging and Pathology Studies on the map

Where is the best place to study Medical Imaging and Pathology Studies?

Among universities, judged by research, Medizinische Hochschule Hannover, University of Chicago and Icahn School of Medicine at Mount Sinai score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%mean 10.74%fractional works in this node (log) →share in the world top 10% →Medizinische Hochschule Hannover: 11, 9.5%University of Chicago: 13, 12.2%Icahn School of Medicine at Mount Sinai: 18, 0.3%University of Pennsylvania: 14, 15.1%Institute of Medical Sciences: 13, 1.8%All India Institute of Medical Sciences: 22, 4.8%Chinese Academy of Medical Sciences & Peking Union Medical College: 20, 8.4%University of California, San Francisco: 10, 18.6%Harvard University: 12, 17.4%University of Wisconsin–Madison: 11, 19.3%University of Pennsy…University of ChicagoMedizinische Hochsch…Icahn School of Medi…
above the meannear itbelow it

One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.

#UniversityScoreTop 10%SpecialisationWorksGrowth
1 Medizinische Hochschule HannoverGermany 50.99.5%9.4×11 +4.5%
2 University of ChicagoUnited States 48.212.2%3.0×13 +150.8%
3 Icahn School of Medicine at Mount SinaiUnited States 48.00.3%6.9×18 +137.5%
4 University of PennsylvaniaUnited States 47.415.1%3.0×14 +13.7%
5 Institute of Medical SciencesIndia 47.31.8%7.6×13 +227.7%
6 All India Institute of Medical SciencesIndia 47.24.8%6.7×22 +2.6%
7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 46.68.4%3.9×20 +40.8%
8 University of California, San FranciscoUnited States 45.318.6%3.1×10 -17.5%
9 Harvard UniversityUnited States 44.617.4%1.8×12 -60.7%
10 University of Wisconsin–MadisonUnited States 42.919.3%2.2×11 -19.3%

Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.

Is Medical Imaging and Pathology Studies research growing?

Output in 2018–2022 was 10% higher than in 2013–2017, peaking in 2024. The fastest-growing topics are Medical Imaging and Pathology Studies.

19801990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.